Zymo Genetics, Inc
Permanently closed
Photos
1201 Eastlake Ave E
Seattle, WA 98102
For more than 25 years, ZymoGenetics has focused on the discovery, development and commercialization of therapeutic proteins. Thanks to a robust discovery program, drug pipelines and development capabilities, ZymoGenetics is an emerging as one of the leaders among biotherapeutic companies. ZymoGenetics is dedicated to the development of protein drugs for the treatment of human diseases. It is focused on promising protein categories and works to define subsets of genes that have some of the highest probabilities of coding for proteins with therapeutic potential. ZymoGenetics is one of the first companies to concentrate solely on therapeutic proteins and has amassed an extensive patent portfolio of more than 300 issued or allowed United States patents. Headquartered in Seattle, ZymoGenetics is a publicly owned company that employs nearly 400 people.
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

